Cosmetic companies facing a patchwork of looming Extended Producer Responsibility (EPR), Post-Consumer Recycled Content (PCR), and other environmental packaging and labeling laws across US states are advised to understand the requirements of each and, where possible, work to help shape policy developments under the regulations.
US State Laws To Address Packaging Waste Are Cosmetics Industry’s Newest Patchwork Problem
Beauty and personal-care companies building a compliance strategy across states should consider starting with California’s SB-54, as it is the “strictest law in place,” experts agreed at the Independent Beauty Association’s recent Supply Chain & Sustainability Conference. They encouraged companies to assess packaging across SKUs and participate in state-level regulatory development processes.
More from ESG
Perrigo's retail customers are expecting real "net zero" progress from consumer health manufacturers, which is in turn driving the firm's sustainability ambitions and expectations from their own suppliers, Perrigo’s UK ethical compliance lead Isobel Gay tells HBW Insight in this exclusive interview.
Pharmaceutical industry associations are united in their view that the revised EU Urban Wastewater Treatment Directive discriminates against medicines and cosmetics producers.
Kenvue's EMEA and LATAM head Carlton Lawson acknowledges the urgency of environmental issues like antimicrobial resistance and wastewater pollution in this interview with HBW Insight, but calls for a more balanced approach on the part of European regulators.
While the majority of British consumers don't want to pay more for eco-conscious products like foods and cosmetics, one in five would pay more for sustainable premium and luxury products and fast-moving consumer goods, reports Clear Channel.
More from HBW Insight
Single-use packaging producers obligated under Oregon’s Extended Producer Responsibility law who still haven’t registered with program facilitators will struggle at this point to meet the fast-approaching material-reporting deadline, but should nonetheless jump into the process, says EPR consultant Michael Washburn.
A round-up of the latest European people moves: PAGB names new president; Enzymatica hires marketing & sales director; Marinomed strengthens supervisory board.
Bayer is investing $52m in its Lerma, Mexico manufacturing site, which the firm said will enable it to increase production of key OTC brands like Aspirin and Alka-Seltzer from 100m to 140m units by 2030.